ProCE Banner Activity

Considerations for Managed Care Professionals in the Care of Patients With Gynecologic Cancer

Clinical Thought

Commentary on considerations for managed care professionals regarding prescription cancer therapy in patients with gynecologic cancers.

Released: June 05, 2024

Expiration: June 04, 2025

Share

Faculty

Laura R. Bobolts

Laura R. Bobolts, PharmD, BCOP

SVP, Clinical Strategy and Growth
OncoHealth
Pompano Beach, Florida 

Kelly Romo

Kelly Romo, PharmD, BCOP

Manager of Oncology Drug Management
Blue Cross Blue Shield of Michigan
Detroit, Michigan

Provided by

Provided by ProCE, LLC in partnership with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and GlaxoSmithKline.

AstraZeneca

GlaxoSmithKline

Partners

Clinical Care Options, LLC

ProCE Banner

Disclosure

Primary Author

Laura R. Bobolts, PharmD, BCOP

SVP, Clinical Strategy and Growth
OncoHealth
Pompano Beach, Florida 

Laura R. Bobolts, PharmD, BCOP, has no relevant financial relationships to disclose.

Kelly Romo, PharmD, BCOP

Manager of Oncology Drug Management
Blue Cross Blue Shield of Michigan
Detroit, Michigan

Kelly Romo, PharmD, BCOP, has no relevant financial relationships to disclose.